UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013446
Receipt number R000015703
Scientific Title The prospective observational study to evaluate a swallowing function and the efficacy of macrolide antibiotics combination therapy in patients with community-acquired pneumonia
Date of disclosure of the study information 2014/03/19
Last modified on 2014/03/17 23:52:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The prospective observational study to evaluate a swallowing function and the efficacy of macrolide antibiotics combination therapy in patients with community-acquired pneumonia

Acronym

Study of swallowing functions and macrolides combination therapy in community acquired therapy

Scientific Title

The prospective observational study to evaluate a swallowing function and the efficacy of macrolide antibiotics combination therapy in patients with community-acquired pneumonia

Scientific Title:Acronym

Study of swallowing functions and macrolides combination therapy in community acquired therapy

Region

Japan


Condition

Condition

Community-acquired pneumonia

Classification by specialty

Pneumology Infectious disease Geriatrics
Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate prospectively a swallowing function in patients acquired hospitalizations due to pneumonia and the efficacy of macrolide antibiotics combination therapy in the treatment of pneumonia

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

30-day and 90-day mortality rates after the admission

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with community-acquired pneumonia(CAP), the definition; 1)infiltrates consistent with CAP seen on a chest radiography, 2)clinical features consistent with CAP, 3)a strong possibility of the affection outside a hospital or long-term care facility.

Key exclusion criteria

1)patients having difficulty in agreement due to consciousness disturbance with no key person, 2)patients with interstitial pneumonia or nontuberculous mycobacterial infections or fungal infections or pulmonary embolism or pneumothorax or pyothorax or severe heart failure
3)hospital-acquired pneumonia(pneumonia that occurs 48 hours or more after hospital admission and that was not present at the time of admission.)

Target sample size

300


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroaki Oka

Organization

Tenshindo Hetsugi Hospital

Division name

Clinical Research Center of Respiratory Medicine

Zip code


Address

5956, Nihongi, Nakahetsugi, Oita-shi, Oita, 879-7761, Japan

TEL

097-597-5777

Email

m10d9007@oita-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroaki Oka

Organization

Tenshindo Hetsugi Hospital

Division name

Clinical Research Center of Respiratory Medicine

Zip code


Address

5956, Nihongi, Nakahetsugi, Oita-shi, Oita, 879-7761, Japan

TEL

097-597-5777

Homepage URL


Email

m10d9007@oita-u.ac.jp


Sponsor or person

Institute

Tenshindo Hetsugi Hospital

Institute

Department

Personal name



Funding Source

Organization

Tenshindo Hetsugi Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 03 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2013 Year 12 Month 18 Day

Date of IRB


Anticipated trial start date

2014 Year 03 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective observational study


Management information

Registered date

2014 Year 03 Month 17 Day

Last modified on

2014 Year 03 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015703


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name